BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bassig BA, Shu XO, Koh WP, Gao YT, Purdue MP, Butler LM, Adams-Haduch J, Xiang YB, Kemp TJ, Wang R. Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts. Int J Cancer. 2015;137:2688-2695. [PMID: 26095604 DOI: 10.1002/ijc.29637] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Liu Z, Mi M, Zhang C, Xiao Y, Liu X, Wu G, Zhang L. Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis. Cancer Manag Res 2019;11:5209-20. [PMID: 31239775 DOI: 10.2147/CMAR.S185030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
2 Bassig BA, Willhauck-fleckenstein M, Shu X, Koh W, Gao Y, Purdue MP, Xiang Y, Adams-haduch J, Wang R, Brenner N, Waterboer T, Michel A, Ji B, Hosgood HD, Rabkin CS, Yang G, Wong JY, Zhang J, Hu W, Seow WJ, Chow W, Pawlita M, Zheng W, Yuan J, Lan Q, Rothman N. Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore: Serologic markers of viral infection and risk of non-Hodgkin lymphoma. Int J Cancer 2018;143:570-9. [DOI: 10.1002/ijc.31385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
3 Purdue MP, Lan Q, Hoffman-Bolton J, Hildesheim A, Callahan CL, Strickland P, Visvanathan K, Rothman N. Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk. Int J Cancer 2019;144:1780-5. [PMID: 30230539 DOI: 10.1002/ijc.31879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Huang YS, Zhou X, Yang ZF, Lv ZT. Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin's lymphomas: evidence from a meta-analysis. Ann Hematol 2018;97:1317-25. [PMID: 29750316 DOI: 10.1007/s00277-018-3349-y] [Reference Citation Analysis]
5 Bassig BA, Shu XO, Sjödin A, Koh WP, Gao YT, Adams-Haduch J, Davis M, Wang R, Xiang YB, Engel LS, Purdue MP, Ji BT, Yang G, Jones RS, Langseth H, Hosgood HD, Grimsrud TK, Seow WJ, Wong JYY, Hu W, Chen D, Zheng W, Yuan JM, Lan Q, Rothman N. Prediagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore. Int J Cancer 2020;146:839-49. [PMID: 31001807 DOI: 10.1002/ijc.32350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
6 Bassig BA, Zhang L, Vermeulen R, Tang X, Li G, Hu W, Guo W, Purdue MP, Yin S, Rappaport SM, Shen M, Ji Z, Qiu C, Ge Y, Hosgood HD, Reiss B, Wu B, Xie Y, Li L, Yue F, Freeman LE, Blair A, Hayes RB, Huang H, Smith MT, Rothman N, Lan Q. Comparison of hematological alterations and markers of B-cell activation in workers exposed to benzene, formaldehyde and trichloroethylene. Carcinogenesis 2016;37:692-700. [PMID: 27207665 DOI: 10.1093/carcin/bgw053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
7 Makgoeng SB, Bolanos RS, Jeon CY, Weiss RE, Arah OA, Breen EC, Martínez-Maza O, Hussain SK. Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies. JNCI Cancer Spectr 2018;2:pky082. [PMID: 30873511 DOI: 10.1093/jncics/pky082] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
8 Vermeulen R, Saberi Hosnijeh F, Bodinier B, Portengen L, Liquet B, Garrido-Manriquez J, Lokhorst H, Bergdahl IA, Kyrtopoulos SA, Johansson AS, Georgiadis P, Melin B, Palli D, Krogh V, Panico S, Sacerdote C, Tumino R, Vineis P, Castagné R, Chadeau-Hyam M, Botsivali M, Chatziioannou A, Valavanis I, Kleinjans JCS, de Kok TMCM, Keun HC, Athersuch TJ, Kelly R, Lenner P, Hallmans G, Stephanou EG, Myridakis A, Kogevinas M, Fazzo L, De Santis M, Comba P, Bendinelli B, Kiviranta H, Rantakokko P, Airaksinen R, Ruokojarvi P, Gilthorpe M, Fleming S, Fleming T, Tu YK, Lundh T, Chien KL, Chen WJ, Lee WC, Kate Hsiao C, Kuo PH, Hung H, Liao SF; EnviroGenoMarkers Consortium Consortium members. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses. Int J Cancer 2018;143:1335-47. [PMID: 29667176 DOI: 10.1002/ijc.31536] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Hosnijeh FS, Portengen L, Späth F, Bergdahl IA, Melin B, Mattiello A, Masala G, Sacerdote C, Naccarati A, Krogh V, Tumino R, Chadeau-hyam M, Vineis P, Vermeulen R. Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses: Circulating soluble markers and risk of B-cell lymphoma. Int J Cancer 2016;138:2357-67. [DOI: 10.1002/ijc.29969] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]